During the past decade, Presence Saint Joseph Hospital-Chicago conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 19 clinical trials were completed, i.e. on average, 475% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Presence Saint Joseph Hospital-Chicago" #1 sponsor was "National Cancer Institute (NCI)" with 8 trials, followed by "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored, "SWOG Cancer Research Network" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "Eastern Cooperative Oncology Group" with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Presence Saint Joseph Hospital-Chicago" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "Aptuit" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Presence Saint Joseph Hospital-Chicago" are "Colorectal Cancer" (4 trials), "Lung Cancer" (3 trials), "Breast Adenocarcinoma" (2 trials), "Breast Cancer" (2 trials) and "HER2/Neu Negative" (2 trials). Many other conditions were trialed in "Presence Saint Joseph Hospital-Chicago" in a lesser frequency.

Most popular intervention types in "Presence Saint Joseph Hospital-Chicago" are "Drug" (24 trials), "Other" (15 trials), "Biological" (10 trials), "Radiation" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Quality-of-Life Assessment" (4 trials), "placebo" (4 trials), "Bevacizumab" (3 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Presence Saint Joseph Hospital-Chicago" are 24 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Presence Saint Joseph Hospital-Chicago". undefined are not yet recruiting, 2 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Presence Saint Joseph Hospital-Chicago, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Presence Saint Joseph Hospital-Chicago, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".